Coenzyme Q10
Also called: CoQ10, ubiquinone, ubidecarenone
A fat-soluble substance naturally present in the human body, highest in the heart, liver, kidneys and pancreas. It carries electrons in mitochondria and acts as a coenzyme for mitochondrial enzymes. Sold in the US as a dietary supplement.
- Category
- Other
- Forms
- Coenzyme Q10 (ubiquinone)
- Strongest evidence
- C Limited
- Reviewed
- 2026-10-28
Class 1 Well studied in people. A 2021 Cochrane review included 11 RCTs (1,573 participants) comparing coenzyme Q10 with placebo or conventional therapy in people with heart failure. [2]
Fact-checked 2026-10-28 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
CHeart and blood vessels2 topics
CCancer1 topic
XBrain, mood and sleep1 topic
XMuscles and exercise1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Heart failure | C | A 2021 Cochrane review (11 studies, 1,573 people) found moderate-quality evidence of lower mortality and hospitalization, but most trials were small with bias risk; it found no convincing evidence to support or refute use. [2] |
| Blood pressure in primary hypertension | C | A 2016 Cochrane review (2 pooled RCTs, 50 participants) found moderate-quality evidence of no clinically significant effect on blood pressure; authors said more well-conducted trials are needed because of the small numbers. [3] |
| Muscle pain from statin drugs | X | NCCIH states that although individual studies varied, the overall evidence does not support CoQ10 reducing statin-related muscle pain. [1] |
| Early Parkinson's disease symptoms | X | A major NIH-funded study found CoQ10, even at higher-than-usual doses, did not improve symptoms; a 2017 evaluation concluded it is not helpful. [1] |
| Cancer | C | NCCIH states CoQ10 has not been shown to be of value in cancer treatment, though it may reduce heart damage from one type of chemotherapy drug. [1] |
Main constituents: Coenzyme Q10 (ubiquinone) [2]
Safety and side effects
- Liver (NIH LiverTox)Score EABCDEA: well known causeE: unlikely cause
NIH LiverTox (last update April 20, 2024): likelihood score E, "unlikely cause of clinically apparent liver injury".
Details and sources - Pregnancy and breastfeedingNothing found
No published information found in the sources checked.
Details and sources - Interactions with medicines3 listed
Warfarin; Insulin; Some cancer treatments
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications2 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- No serious side effects have been reported. Mild side effects such as insomnia or digestive upsets may occur. [1]
Interactions
| With | What happens |
|---|---|
| Warfarin | CoQ10 may interact with the anticoagulant warfarin. [1] |
| Insulin | CoQ10 may interact with the diabetes drug insulin. [1] |
| Cancer treatments | CoQ10 may not be compatible with some types of cancer treatment. [1] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Regulatory status
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Coenzyme Q10 (ubiquinone with a side chain of 10 isoprenoid units; also called ubiquinone) Ubiquinone (quinone with an isoprenoid side chain) [P4]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 2 entries naming ubiquinol (earliest NDI 311 submitted 2004-12-03; most recent NDI 328 submitted 2005-05-05). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. No entry names coenzyme Q10, CoQ10, ubiquinone or ubidecarenone. [P1]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- No IARC or NTP carcinogenicity evaluation of coenzyme Q10 was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P3]
Liver (NIH LiverTox)
- NIH LiverTox (last update April 20, 2024): likelihood score E, "unlikely cause of clinically apparent liver injury". [P5]
Interactions with medicines
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test or examination of the dietary ingredient — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants a petition for an exemption under 111.75(a)(1)(ii). [P2]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- Bhagavan and Chopra (review, 2006): because of its hydrophobicity and large molecular weight, absorption of dietary CoQ10 is slow and limited; Tmax is around 6 h with an elimination half-life of about 33 h; reference intervals for plasma CoQ10 are 0.40–1.91 micromol/l in healthy adults. Solubilized formulations are reported to show enhanced bioavailability (no figures in the abstract). The first author's listed affiliation is Tishcon Corporation (Westbury, NY). [P7]
- LiverTox: CoQ10 is fat-soluble and is often taken with lipids or vitamin E to aid uptake. [P5]
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- No published information found in the sources checked.
Sources for this profile
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- eCFR. 21 CFR 111.75 What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- IARC Monographs. List of Classifications (checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
- PubChem. Coenzyme Q10, CID 5281915 (description from ChEBI; retrieved via PUG-REST 2026-10-29), 2026-10-29. pubchem.ncbi.nlm.nih.gov
- NIH LiverTox. Coenzyme Q10 (last update April 20, 2024), 2024-04-20. ncbi.nlm.nih.gov
- NCCIH. Coenzyme Q10 (last updated January 2019), 2019-01. nccih.nih.gov
- Bhagavan HN, Chopra RK. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res 2006;40(5):445-53 (PMID 16551570), 2006-05. pubmed.ncbi.nlm.nih.gov
Sources
- NCCIH. Coenzyme Q10 (Last Updated: January 2019), 2019-01. nccih.nih.gov
- Al Saadi T, et al. Coenzyme Q10 for heart failure. Cochrane Database of Systematic Reviews 2021, CD008684 (PubMed abstract), 2021-02-03. pubmed.ncbi.nlm.nih.gov
- Ho MJ, Li EC, Wright JM. Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension. Cochrane Database of Systematic Reviews 2016, CD007435 (PubMed abstract), 2016-03-03. pubmed.ncbi.nlm.nih.gov
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (Content current as of 08/27/2026), 2026-08-27. fda.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in this category: Alpha-lipoic acid · Bee pollen · Beetroot juice (dietary nitrate) · Berberine · Beta-glucan (oat and barley) · Betaine (trimethylglycine) · Bromelain · Caffeine · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.